KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Other Non-Current Liabilities: 2018-2025

Historic Other Non-Current Liabilities for Guardant Health (GH) over the last 7 years, with Sep 2025 value amounting to $94.4 million.

  • Guardant Health's Other Non-Current Liabilities rose 5.49% to $94.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $94.4 million, marking a year-over-year increase of 5.49%. This contributed to the annual value of $92.8 million for FY2024, which is 3.30% down from last year.
  • Per Guardant Health's latest filing, its Other Non-Current Liabilities stood at $94.4 million for Q3 2025, which was up 3.50% from $91.2 million recorded in Q2 2025.
  • In the past 5 years, Guardant Health's Other Non-Current Liabilities registered a high of $96.8 million during Q1 2024, and its lowest value of $1.7 million during Q1 2021.
  • Moreover, its 3-year median value for Other Non-Current Liabilities was $92.5 million (2025), whereas its average is $70.7 million.
  • As far as peak fluctuations go, Guardant Health's Other Non-Current Liabilities soared by 959.39% in 2024, and later dropped by 4.97% in 2025.
  • Over the past 5 years, Guardant Health's Other Non-Current Liabilities (Quarterly) stood at $3.9 million in 2021, then spiked by 133.38% to $9.2 million in 2022, then spiked by 945.93% to $96.0 million in 2023, then declined by 3.30% to $92.8 million in 2024, then grew by 5.49% to $94.4 million in 2025.
  • Its last three reported values are $94.4 million in Q3 2025, $91.2 million for Q2 2025, and $92.5 million during Q1 2025.